Heart Failure 2018 & World Congress on Acute Heart Failure

26 - 29 May 2018, Vienna - Austria

Session Details

Late breaking trial II - Chronic heart failure
Sun 27 May 08:30 - 10:00 Chronic Heart Failure Special Session, Mobile App - Ask a Question Vienna -
Chairpersons: Eugene BRAUNWALD (Boston, United States of America), Frank RUSCHITZKA (Zurich, Switzerland)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30670The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming: Secondary outcomes and per protocol analysis of an international multicenter RCT Tiny JAARSMA (Norrkoping, Sweden)
08:40671Discussion - HF-WiiLoreena HILL (Co.Antrim, GB)
08:45672Diabetes and obesity in heart failure: a crossroads for prognosis and the efficacy of beta-blockersDipak KOTECHA (Birmingham, United Kingdom)
08:55673Discussion - BB-meta-HFPetar SEFEROVIC (Belgrade, RS)
09:00674Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure: GENETIC-AFWilliam ABRAHAM (Columbus, United States of America)
09:10675Discussion - GENETIC-AFChristopher O'CONNOR (Durham, US)
09:15676Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist deviceAlexander LYON (London, United Kingdom)
09:25677Discussion - SERCA-LVAD TRIALMaria G CRESPO-LEIRO (La Coruna, ES)
09:30678Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort Gianluigi SAVARESE (Stockholm, Sweden)
09:40679Discussion - RASi in elderly patients with HFrEFWilfried MULLENS (Genk, BE)
09:45680Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysisMichel KOMAJDA (Paris, France)
09:55681Discussion - Therapies for HFrEF: network meta-analysisMitja LAINSCAK (Murska Sobota, SI)